1 June 2017 · To support NHS compounding units and purchasers to derive and assess stability data for pharmaceutical products (Specials and extemporaneously compounded).
23 January 2017 · This YCD applies to small molecule products of all presentations prepared by aseptic manipulation of sterile pharmaceutical products.
29 February 2016 · This document is intended to cover stability testing of all oral liquid formulations including suspensions, emulsions, solutions and powders for reconstitution
20 October 2021 · Local decision makers should choose between the options for giving fidaxomicin orally. Licensing status and other factors affect decision making.
18 May 2021 · Local decision makers should choose between the options for giving vancomycin orally. Licensing status and other factors affect decision making.
18 September 2019 · This document aims to provide guidance to NHS Chief Pharmacists and Accountable Pharmacists working under the Section 10 exemption to the Medicines Act 1968 on…
16 December 2016 · Variation in practice underlined the need for an evidence-based guideline for handling mAbs that was suited to all those providing care to NHS patients.
25 May 2010 · This document is intended to provide a guidance framework for NHS Specials’ manufacturing activity for a consistent and risk-based approach to evaluate and approve suppliers…